Physician-Thoracic Medical Oncologist

Physician-Thoracic Medical Oncologist

Ochsner Health is seeking a Board Certified/Board Eligible Thoracic Medical Oncologist Physician. Ochsner Health is an integrated healthcare system with more than 36,000 employees and over 4,600 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 47 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South.

Ochsner MD Anderson Cancer Center is one of only seven MD Anderson Cancer Center partners in the country and the only one in Louisiana. It joins a collaborative network of hospitals and health care systems dedicated to advancing MD Anderson's mission to improve the quality and accessibility of cancer care and research. As such, Ochsner MD Anderson patients in southeastern Louisiana receive care based on the same protocols and practice standards provided at MD Anderson in Houston, Texas, and benefit from integration with its clinicians and researchers. Ochsner MD Anderson experts adhere to the philosophy, process and guidelines of MD Anderson's clinical leadership, and they provide a full range of multidisciplinary care options, including medical oncology, surgery and radiation.

Aside from inpatient and outpatient patient care responsibilities, candidates have the opportunity to participate in or develop clinical research studies, teach fellows and residents, and contribute to the development of the program. Subspecialty interest is encouraged but not required for consideration for the New Orleans Main Campus positions. Candidates must be board certified or board eligible in hematology and oncology.

Ochsner is the leading clinical oncology program in the Gulf South Region. For over 75 years, we have been dedicated to cancer research and new cancer treatment developments, with more clinical trials than anywhere else in the region. In the past year, Ochsner has provided both personalized and state-of-the-art care to more than 15,000 cancer patients. Our multi-disciplinary approach, advanced technologies, and focus on clinical research and our Precision Cancer Therapies Program, define our approach to cancer care.